·   Log in

Posts Tagged ‘ranbaxy’

Daiichi-Ranbaxy to supply Nuvo’s wound healing agent Oxoferin in Asian countries

Friday, November 13, 2009 15:41

Daiichi-Ranbaxy has tied up with Canada-based transdermal drug development firm Nuvo Research Inc to supply a topical wound healing agent Oxoferin in some Asian countries.

This was posted under category: Pharma  |  Read Full Story  |  0 Comments
Tagged with: ,

Ranbaxy’s anti-HIV drug Indinavir gets WHO prequalification

Friday, November 13, 2009 13:04

Indinavir, anti HIV drug from Ranbaxy Laboratories Limited has been included pre-qualification list of  the World Health Organisation, Geneva (WHO), the company announced.

This was posted under category: Industry  |  Read Full Story  |  0 Comments
Tagged with: , ,

Isotretinoin generics face withdrawal threat in US as new study links acne drug to bowel disease

Monday, November 9, 2009 17:08

Ranbaxy has a generic version of isotretinoin (Accutane) in US market branded as Isotret

This was posted under category: Industry  |  Read Full Story  |  0 Comments
Tagged with: ,

Ranbaxy honours scientists & young scholars in pharma and medicine research

Thursday, November 5, 2009 15:14

Ranbaxy Science Foundation (RSF), a non-profit organization set-up by Ranbaxy Laboratories Limited (RLL), has honoured Indian researchers in pharma and medicine for their outstanding contributions in its 21st Annual Research Awards for the year 2008

This was posted under category: Pharma  |  Read Full Story  |  0 Comments
Tagged with:

Ranbaxy exits Vietnam business; expects US FDA will lift ban on Dewas facility soon

Monday, November 2, 2009 15:22

Daiichi Sankyo-controlled Ranbaxy Laboratories has sold its Vietnam business, as part of the company's ongoing restructuring operations. Ranbaxy may soon sell another of its business soon as it wants to divest of some of its loss making businesses, Ranbaxy CEO and MD Atul Sobti has stated. “We have divested the Vietnam operations ...

This was posted under category: Industry  |  Read Full Story  |  0 Comments

Purdue Pharma sues Ranbaxy on generic OxyContin (oxycondone) patent rights in US

Tuesday, October 27, 2009 12:02

OxyContin was the ninth most-selling drug in the US in 2008 with sales of $2.5 billion

This was posted under category: Featured, Patents  |  Read Full Story  |  0 Comments

India, South Africa sales boost Ranbaxy’s Q2 earnings for 2009

Monday, October 26, 2009 13:48

Daiichi-controlled Ranbaxy Laboratories Ltd has posted a third-quarter profit before tax at USD 33 Mn (Rs. 1,601 Mn) with an EBITDA margin of 13% to sales for the quarter ending on September 30, boosted by eranings fro emerging market sales including India and South Africa. Net income was 1.17 billion rupees ...

This was posted under category: Industry  |  Read Full Story  |  0 Comments
Tagged with: ,

European antitrust officials raid Ranbaxy’s French unit

Wednesday, October 7, 2009 19:02

Indian drug maker Ranbaxy' unit in France has been raided by European antitrust regulators.

This was posted under category: Industry  |  Read Full Story  |  0 Comments
Tagged with: , ,
Validus chooses Ranbaxy as partner to sell calcium deficiency drug generic calictriol in US

Validus chooses Ranbaxy as partner to sell calcium deficiency drug generic calictriol in US

Thursday, September 3, 2009 14:19

Ranbaxy Pharmaceuticals Inc has been selected by Validus Pharmaceuticals LLC as its marketing partner for  distributing an authorized generic version of calcitriol in both softgel capsules and an oral liquid formulation in US.

This was posted under category: Industry  |  Read Full Story  |  0 Comments
Tagged with: ,

India boosts oseltamivir stockpile to 30 million doses; buys another 900,000 swine flu pills from Ranbaxy

Wednesday, September 2, 2009 14:38

Indian government has initaited a major boost to its oseltamivir stock pile even as the death toll of H1N1 influenza A or swine flu has touched the 100 mark.

This was posted under category: Featured, health  |  Read Full Story  |  0 Comments